Literature DB >> 1747948

Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1-helix.

R Lahesmaa1, M Skurnik, M Vaara, M Leirisalo-Repo, M Nissilä, K Granfors, P Toivanen.   

Abstract

Two new examples of amino acid homology between HLA B27 and microbes triggering HLA B27-associated diseases are described. An outer membrane protein YadA (Yersinia adhesin, previously called Yop1) of Yersinia enterocolitica and Y. pseudotuberculosis shares a linear tetrapeptide with HLA B27. A cationic outer membrane protein OmpH of Salmonella typhimurium shares homology with five amino acids of HLA B27 in a non-linear fashion. The four amino acids of YadA are also notably included in the hexapeptide identical between Klebsiella pneumoniae nitrogenase and HLA B27, and three of them occur in the pentapeptide shared by a Shigella flexneri protein and HLA B27. Antibodies against synthetic peptides including HLA B27 homologues sequences of YadA and OmpH were observed in one-third of the patients with HLA B27 associated diseases. Antibodies were directed against a flanking sequence next to the amino acid sequences shared by arthritis-triggering microbes and HLA B27. The area of identity in each example of this molecular mimicry (Yersinia, Salmonella, Shigella and Klebsiella) is located in the same place on the HLA B27 molecule: between amino acids 70 to 78 in the variable region of alpha 1-helix. This area of HLA B27 molecule includes sites predicted to be important for binding processed antigens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747948      PMCID: PMC1554211          DOI: 10.1111/j.1365-2249.1991.tb02944.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Bacterial 'histone-like protein I' (HLP-I) is an outer membrane constituent?

Authors:  L Hirvas; J Coleman; P Koski; M Vaara
Journal:  FEBS Lett       Date:  1990-03-12       Impact factor: 4.124

2.  Bacterial epitopes involved in the induction of reactive arthritis.

Authors:  H Stieglitz; S Fosmire; P E Lipsky
Journal:  Am J Med       Date:  1988-12-23       Impact factor: 4.965

3.  Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis.

Authors:  G Husby; N Tsuchiya; P L Schwimmbeck; A Keat; J A Pahle; M B Oldstone; R C Williams
Journal:  Arthritis Rheum       Date:  1989-04

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 5.  Solid-phase peptide synthesis.

Authors:  R B Merrifield
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

6.  Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia.

Authors:  C G van Bohemen; F C Grumet; H C Zanen
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

7.  Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

Authors:  J Roudier; J Petersen; G H Rhodes; J Luka; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Cloning and sequencing of the gene for the DNA-binding 17K protein of Escherichia coli.

Authors:  A Holck; K Kleppe
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

9.  Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.

Authors:  J Welsh; H Avakian; P Cowling; A Ebringer; P Wooley; G Panayi; R Ebringer
Journal:  Br J Exp Pathol       Date:  1980-02

10.  Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera.

Authors:  H Avakian; J Welsh; A Ebringer; C C Entwistle
Journal:  Br J Exp Pathol       Date:  1980-02
View more
  14 in total

Review 1.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 2.  HLA-B27 and bacteria.

Authors:  J Uksila; P Toivanen
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis.

Authors:  Riitta Tuompo; Timo Hannu; Elisa Huovinen; Leila Sihvonen; Anja Siitonen; Marjatta Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2017-09-16       Impact factor: 2.631

Review 4.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

Review 5.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

Review 6.  Juvenile onset spondyloarthropathies: therapeutic aspects.

Authors:  R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

Review 7.  Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?

Authors:  R Lahesmaa; M Skurnik; P Toivanen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

8.  The effects of Helicobacter pylori infection on intraocular pressure in anterior uveitis.

Authors:  J M Kim; K H Park; M J Choi; M M Ha; Y H Sohn; H K Kim; J Caprioli
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

Review 9.  Aspects of histocompatibility testing in xenotransplantation.

Authors:  Joseph M Ladowski; Julie Houp; Vera Hauptfeld-Dolejsek; Mariyam Javed; Hidetaka Hara; David K C Cooper
Journal:  Transpl Immunol       Date:  2021-05-17       Impact factor: 2.032

10.  Short peptide sequence identity between human viruses and HLA-B27-binding human 'self' peptides.

Authors:  Shipeng Sun; Tao Wang; Bo Pang; Huamin Wei; Guijian Liu
Journal:  Theory Biosci       Date:  2013-12-22       Impact factor: 1.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.